BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18286686)

  • 1. Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma.
    Jethwa P; Naqvi M; Hardy RG; Hotchin NA; Roberts S; Spychal R; Tselepis C
    World J Gastroenterol; 2008 Feb; 14(7):1044-52. PubMed ID: 18286686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-CADERIN, N-CADERIN, SLUG, SNAIL, and TWIST contribute to epithelial-mesenchymal transition in salivary gland tumors.
    de Santana DA; Braga PR; Camillo-Coutinho CM; Freitas VS; Cury PR; Ribeiro DA; de Araújo IB; de Aquino Xavier FC; Dos Santos JN
    J Oral Pathol Med; 2024 Mar; 53(3):193-200. PubMed ID: 38351435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous wound reepithelialization is compromised in mice lacking functional Slug (Snai2).
    Hudson LG; Newkirk KM; Chandler HL; Choi C; Fossey SL; Parent AE; Kusewitt DF
    J Dermatol Sci; 2009 Oct; 56(1):19-26. PubMed ID: 19643582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
    Sbiera I; Kircher S; Altieri B; Fassnacht M; Kroiss M; Sbiera S
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Insights Delineating the Role of Cholesterol in Epithelial Mesenchymal Transition and Drug Resistance in Cancer.
    Abdulla N; Vincent CT; Kaur M
    Front Cell Dev Biol; 2021; 9():728325. PubMed ID: 34869315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double Agent:
    Ye T; Feng J; Wan X; Xie D; Liu J
    Cancer Manag Res; 2020; 12():3891-3902. PubMed ID: 32547225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the microRNA-200 Family, microRNA-205, and Markers of Epithelial-Mesenchymal Transition as Predictors for Endoscopic Submucosal Dissection over Esophagectomy in Esophageal Adenocarcinoma: A Single-Center Experience.
    Neureiter D; Mayr C; Winkelmann P; Neumayer B; Klieser E; Wagner A; Hufnagl C; Emmanuel K; Holzinger J; Koch O; Kiesslich T; Varga M
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells.
    Zhang Q; Agoston AT; Pham TH; Zhang W; Zhang X; Huo X; Peng S; Bajpai M; Das K; Odze RD; Spechler SJ; Souza RF
    Gastroenterology; 2019 Jan; 156(1):130-144.e10. PubMed ID: 30268789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
    Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH
    PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking and gender modify the effect of
    Zhu Y; Zhang W; Wang P
    Oncotarget; 2017 Oct; 8(49):85816-85827. PubMed ID: 29156759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
    Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
    Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.
    Kestens C; Siersema PD; Offerhaus GJ; van Baal JW
    PLoS One; 2016; 11(5):e0155754. PubMed ID: 27191723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.
    Naini BV; Souza RF; Odze RD
    Am J Surg Pathol; 2016 May; 40(5):e45-66. PubMed ID: 26813745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma.
    Taylor C; Loomans HA; Le Bras GF; Koumangoye RB; Romero-Morales AI; Quast LL; Zaika AI; El-Rifai W; Andl T; Andl CD
    Oncotarget; 2015 Oct; 6(33):34228-44. PubMed ID: 26447543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cells.
    Tsukasa K; Ding Q; Yoshimitsu M; Miyazaki Y; Matsubara S; Takao S
    Hum Cell; 2015 Oct; 28(4):167-74. PubMed ID: 25997702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
    Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
    J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slug is a predictor of poor prognosis in esophageal squamous cell carcinoma patients.
    Hasan MR; Sharma R; Saraya A; Chattopadhyay TK; DattaGupta S; Walfish PG; Chauhan SS; Ralhan R
    PLoS One; 2013; 8(12):e82846. PubMed ID: 24367561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the epithelial mesenchymal transition phenotype in cancer of unknown primary from a global microRNA profiling study.
    Stoyianni A; Pentheroudakis G; Benjamin H; Cervantes A; Ashkenazi K; Lazaridis G; Pavlidis N; Spector Y
    Clin Transl Oncol; 2014 Aug; 16(8):725-31. PubMed ID: 24282096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of Snail decreases breast cancer cell motility by downregulating the expression and inhibiting the activity of RhoA GTPase.
    Zhang A; Wang Q; Han Z; Hu W; Xi L; Gao Q; Wang S; Zhou J; Xu G; Meng L; Chen G; Ma D
    Oncol Lett; 2013 Aug; 6(2):339-346. PubMed ID: 24137327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction.
    Clemons NJ; Phillips WA; Lord RV
    Cancer Biol Ther; 2013 Sep; 14(9):782-95. PubMed ID: 23792587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.